135 related articles for article (PubMed ID: 24639918)
1. Obesity is associated with higher 4E-BP1 expression in endometrial cancer.
Libby EF; Azrad M; Novak L; Vazquez AI; Wilson TR; Demark-Wahnefried W
Curr Biomark Find; 2014 Jan; 2014(4):1-7. PubMed ID: 24639918
[TBL] [Abstract][Full Text] [Related]
2. Impact of the Activation Status of the Akt/mTOR Signalling Pathway on the Clinical Behaviour of Synovial Sarcoma: Retrospective Analysis of 174 Patients at a Single Institution.
Li YX; Ding SS; Wen WJ; Han L; Wang HQ; Shi HY
Cancer Manag Res; 2020; 12():1759-1769. PubMed ID: 32210617
[TBL] [Abstract][Full Text] [Related]
3. The expression and significance of p4E-BP1/4E-BP1 in prostate cancer.
Wang KY; Wang KJ; Ma Q
J Clin Lab Anal; 2022 Apr; 36(4):e24332. PubMed ID: 35257419
[TBL] [Abstract][Full Text] [Related]
4. Expression of phosphorylated eIF4E-binding protein 1, but not of eIF4E itself, predicts survival in male breast cancer.
Millican-Slater RA; Sayers CD; Hanby AM; Hughes TA
Br J Cancer; 2016 Jul; 115(3):339-45. PubMed ID: 27280636
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of the activation status of the Akt/mTOR pathway in synovial sarcoma.
Setsu N; Kohashi K; Fushimi F; Endo M; Yamamoto H; Takahashi Y; Yamada Y; Ishii T; Yokoyama K; Iwamoto Y; Oda Y
Cancer; 2013 Oct; 119(19):3504-13. PubMed ID: 23861137
[TBL] [Abstract][Full Text] [Related]
6. Activation of the Akt/mammalian target of rapamycin pathway in combined hepatocellular carcinoma and cholangiocarcinoma: significant correlation between p-4E-BP1 expression in cholangiocarcinoma component and prognosis.
Okumura Y; Kohashi K; Tanaka Y; Kato M; Maehara Y; Ogawa Y; Oda Y
Virchows Arch; 2020 Jun; 476(6):881-890. PubMed ID: 31927624
[TBL] [Abstract][Full Text] [Related]
7. Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers.
Zhou X; Tan M; Stone Hawthorne V; Klos KS; Lan KH; Yang Y; Yang W; Smith TL; Shi D; Yu D
Clin Cancer Res; 2004 Oct; 10(20):6779-88. PubMed ID: 15501954
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of phosphorylated 4E-BP1 predicts for tumor recurrence and reduced survival in cervical carcinoma treated with postoperative radiotherapy.
Benavente S; Vergés R; Hermosilla E; Fumanal V; Casanova N; García A; Ramón Y Cajal S; Giralt J
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1316-22. PubMed ID: 19362787
[TBL] [Abstract][Full Text] [Related]
9. Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 expression in endometrial cancer correlates with aggressive tumors and prognosis.
Castellvi J; Garcia A; Ruiz-Marcellan C; Hernández-Losa J; Peg V; Salcedo M; Gil-Moreno A; Ramon y Cajal S
Hum Pathol; 2009 Oct; 40(10):1418-26. PubMed ID: 19428047
[TBL] [Abstract][Full Text] [Related]
10. Expression profiles of mTOR pathway proteins in porocarcinoma: A provisional immunohistochemical study.
Ishida M; Okabe H
Biomed Rep; 2013 Jan; 1(1):28-30. PubMed ID: 24648888
[TBL] [Abstract][Full Text] [Related]
11. mTOR signaling pathway in penile squamous cell carcinoma: pmTOR and peIF4E over expression correlate with aggressive tumor behavior.
Ferrandiz-Pulido C; Masferrer E; Toll A; Hernandez-Losa J; Mojal S; Pujol RM; Ramon y Cajal S; de Torres I; Garcia-Patos V
J Urol; 2013 Dec; 190(6):2288-95. PubMed ID: 23764082
[TBL] [Abstract][Full Text] [Related]
12. Phospho-4e-BP1 and eIF4E overexpression synergistically drives disease progression in clinically confined clear cell renal cell carcinoma.
Campbell L; Jasani B; Griffiths DF; Gumbleton M
Am J Cancer Res; 2015; 5(9):2838-48. PubMed ID: 26609489
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas.
Korkolopoulou P; Levidou G; El-Habr EA; Piperi C; Adamopoulos C; Samaras V; Boviatsis E; Thymara I; Trigka EA; Sakellariou S; Kavantzas N; Patsouris E; Saetta AA
Histopathology; 2012 Aug; 61(2):293-305. PubMed ID: 22690797
[TBL] [Abstract][Full Text] [Related]
14. AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis.
Mi W; Ye Q; Liu S; She QB
Oncotarget; 2015 Jun; 6(16):13962-77. PubMed ID: 25961827
[TBL] [Abstract][Full Text] [Related]
15. Mammalian target of rapamycin signaling activation patterns in pancreatic neuroendocrine tumors.
Komori Y; Yada K; Ohta M; Uchida H; Iwashita Y; Fukuzawa K; Kashima K; Yokoyama S; Inomata M; Kitano S
J Hepatobiliary Pancreat Sci; 2014 Apr; 21(4):288-95. PubMed ID: 24002888
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Akt/mTOR signaling in primary breast tumors and matched distant metastases.
Akcakanat A; Sahin A; Shaye AN; Velasco MA; Meric-Bernstam F
Cancer; 2008 Jun; 112(11):2352-8. PubMed ID: 18386830
[TBL] [Abstract][Full Text] [Related]
18. Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer.
Meric-Bernstam F; Chen H; Akcakanat A; Do KA; Lluch A; Hennessy BT; Hortobagyi GN; Mills GB; Gonzalez-Angulo A
Breast Cancer Res; 2012 Oct; 14(5):R138. PubMed ID: 23102376
[TBL] [Abstract][Full Text] [Related]
19. Significance of 4E-binding protein 1 as a therapeutic target for invasive urothelial carcinoma of the bladder.
Nishikawa M; Miyake H; Behnsawy HM; Fujisawa M
Urol Oncol; 2015 Apr; 33(4):166.e9-15. PubMed ID: 25618298
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylated 4E-binding protein 1 expression is associated with poor prognosis in small-cell lung cancer.
Roh MS; Lee JH; Kang KW; Nam HY; Jung SB; Kim K; Lee EH; Park MI; Kim MS; Lee HW
Virchows Arch; 2015 Dec; 467(6):667-673. PubMed ID: 26445970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
